SCHEMBL17799653

SCHEMBL17799653

O=C(N[C@H]1CC[C@H]1c1ccc(Cl)cc1)c1ccoc1Br

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ AKT1 P31749 11/20 0.39
▸ TAS1R3 Q7RTX0 1/20 0.38
▸ TAS1R1 Q7RTX1 1/20 0.38
▸ TAS1R2 Q8TE23 1/20 0.38
▸ HTR3E A5X5Y0 1/20 0.37
▸ HTR3B O95264 1/20 0.37
▸ ALOX15 P16050 1/20 0.37
▸ TSHR P16473 1/20 0.37
▸ CHRNA7 P36544 1/20 0.37
▸ HTR3A P46098 1/20 0.37
▸ HTR3D Q70Z44 1/20 0.37
▸ HTR3C Q8WXA8 1/20 0.37
▸ FPR1 P21462 3/20 0.37
▸ FPR2 P25090 2/20 0.37
▸ TLR2 O60603 1/20 0.36
▸ TLR1 Q15399 1/20 0.36
▸ LMNA P02545 1/20 0.36
▸ GLA P06280 1/20 0.36
▸ MAPK1 P28482 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16372326 0.85 LMNA (0.53) TAS1R3TAS1R1TAS1R2TSHRLMNA
SCHEMBL17799718 0.85 LMNA (0.53) TAS1R3TAS1R1TAS1R2TSHRLMNA
SCHEMBL17799666 0.83 TAS1R3 (0.43) TAS1R3TAS1R1TAS1R2
SCHEMBL17799673 0.82 TAS1R3 (0.36) AKT1TAS1R3TAS1R1TAS1R2FPR1
SCHEMBL17799635 0.80 L3MBTL1 (0.46) FPR1FPR2LMNA
SCHEMBL17799658 0.78 FPR1 (0.37) AKT1TAS1R3TAS1R1TAS1R2HTR3E
SCHEMBL17799705 0.76 NPC1 (0.47) FPR1FPR2
SCHEMBL17799709 0.75 TAS1R3 (0.40) AKT1TAS1R3TAS1R1TAS1R2FPR1
SCHEMBL17799637 0.74 GRM5 (0.47) FPR1FPR2
SCHEMBL16372277 0.74 SIGMAR1 (0.48) TAS1R3TAS1R1TAS1R2FPR1FPR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE50724-E1 4-membered ring carboxamides used as nematicides SYNGENTA CROP PROTECTION AG (CH) 2026-01-06 — — US disclosed
EP-3019476-B1 4-MEMBERED RING CARBOXAMIDES USED AS NEMATICIDES SYNGENTA PARTICIPATIONS AG (CH) 2018-01-17 — — EP disclosed
US-9867371-B2 4-membered ring carboxamides used as nematicides SYNGENTA PARTICIPATIONS AG (CH) 2018-01-16 — — US disclosed
US-20160157485-A1 4-MEMBERED RING CARBOXAMIDES USED AS NEMATICIDES SYNGENTA PARTICIPATIONS AG (CH) 2016-06-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160157485-A1 4-MEMBERED RING CARBOXAMIDES USED AS NEMATICIDES TUBA3C, DDT, CYCS AKT1 4061/4885TAS1R3 3195/4885TAS1R1 3418/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback